Navigation Links
Seroquel to Treat Depression In Case Of Bipolar Disorder

AstraZeneca the Head of the Anglo-Swedish Company has come out with the results of the drug Seroquel stating that it be used in the treatment of // both maniac behaviour and mental depression in people suffering with bipolar disorders.

He has asked US to consider his drug as a sole treatment for maniac and depression symptoms related to bipolar disorder.

AstraZeneca, the drug czar has requested the number of drug regulators spread across the Atlantic to approve Seroquel.

Previously the drug was given permission to be used in the treatment of mania.

But now with his research and other works done at the base in Alderley Edge he has supplied new information based on clinical trail that it is very effective in treating patients suffering from mental depression.

Bipolar disorder is a characteristic mental imbalance in which the individual experience severe mood swings and also feels euphoric during episodes of mania and then immediately suffers from the lows characteristic of mental depression.

The incidence of this disease is very low and is about 3-4 % among the adults. It is the sixth leading cause of disability in the world.

Doctors say that the condition might be associated with genes and may be hereditary. It affects equal number of patients in both the sexes.

The acquiescence of the license for the new drug from the US Food and Drug Administration (FDA) would be an important milestone in the history of the drug.

The drug Seroquel alone spawned a profit of 1.16 billion pounds in 2004.


'"/>




Page: 1

Related medicine news :

1. Astra Zenecas Seroquel Gets FDA Approval For Schizophrenia
2. Advances in Treatment of Cataracts
3. Recommendations for Treatment of Blood Pressue
4. New FDA Approved Drug To Treat Migraine
5. Treatment for Menieres disease
6. Treatment for pre-menstrual syndrome is ineffective
7. Angiotensin-II-receptor blockers - Treat kidney failure
8. Cipro Has Cheaper Cousins to Treat Anthrax
9. Better Treatment for obesity
10. Gene Treatment for Heart Disease
11. Cyclosporin A Treats Leukemia Complications

Post Your Comments:
(Date:12/4/2009)... the H1N1 virus will come back during winter isn,t...ealthDay News) -- The number of states reporting w...this week -- to 25 from a high of 48 just two week...anwhile, the supply of H1N1 swine flu vaccine cont... of the U.S. Centers for Disease Control and Preve...
(Date:12/4/2009)...s more smoke inhaled through hookah, research show... Water pipes are no safer than cigarettes for smok...nd that people who smoke tobacco with a water pipe...hem at risk for heart disease and nicotine addicti... to 50, who smoked tobacco using a water pipe and ...
(Date:12/4/2009)...tudy found they spurred blood vessel growth after ...ay News) -- Adult stem cells appear to help repair...phase 1 study of 53 patients found that stem cells... blood vessels in heart tissue damaged by heart at...ections within 10 days of having a heart attack. D...
(Date:12/4/2009)... , MADISON, Wis., Dec. 4 /PRNewswire-FirstCall...fall, the Wisconsin Department of Health Services ... quickly than ever before. Join Sonic Foundry, In... for rich media webcasting and knowledge managemen... Wisconsin Department of Health Services, will sha...
(Date:12/4/2009)... , BOULDER, Colo., Dec. 4 ... ON LOVE ,, Kathryn Budig, a prominent yoga tea... to healing--with a viewing of Twilight,s New Moon...al.com: ,, http://www.elephantjournal.com/2009...urnal.com: TASHI KING AND BREAST CANCER ,, ele...
Breaking Medicine News(10 mins):Health News:Swine Flu Continues to Wane 2Health News:Water Pipes No Safer Than Cigarettes 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 3
...lthcare, a division of the $150-billion General El...nce with Manipal Health Systems (MHS) to conduct c...dia. The trials will be conducted at the Bang...spital for $7 million and invested another $1.5-2 ...
...ds of jobs will be terminated and hospital wards w...Hospital is struggling with financial pressures//....sion made by primary care center to refer fewer pa... Unison’s Geoff Reason, describing the news as ...
...istopher Landrigan, from Harvard University, a spe...red a report on the repercussions of lack of sleep... been deputed by the health board to lend his obse...e reaching a stalemate. Dr Stephen Child, th...
...ine, to prevent the attack of the deadly bird flu ...es, after the initial trial reports announce it sa...cine, developed by Melbourne pharmaceutical manufa... bird flu and is the only one of its kind, being d...
...l misconceptions have prevented many people espec...ng eggs//. The July issue of the Harvard Heart Let...the egg. Fact: Eggs are a good source of nutr...serving memory, and lutein and zeaxanthin, which m...
...er Army Major questioned a particular research, wh...sed cancer rates among those who took part in Brit...their exposure to radiation//. According to th...to their exposure to radiation. However Vetera...
Other Medicine News:Health News:GE Healthcare to Conduct Clinical Trials in India 2
(Date:12/4/2009)..., ANNAPOLIS, Md., Dec. 4 /PRNewswire-FirstCall/...ense company developing medical countermeasures ag...oday the presentation of new data from the Company...lized recombinant Protective Antigen (rPA) based a...fter 16 months at various temperatures up to and i...
(Date:12/4/2009)..., ANNAPOLIS, Md., Dec. 4 /PRNewswire-FirstCall/ -...se company developing medical countermeasures agai...ay that the Company is presenting results of a stu...4; in an inhalation anthrax model in the New Zeala...ed during an oral session at the HHS Public Health...
(Date:12/4/2009)... , MORRISTOWN, N.J., Dec. 4 /PRNewswire-FirstCa..., a leading global specialty pharmaceutical compan...oratories, Inc.-Florida, filed an Abbreviated New ...g Administration seeking approval to market its 8m...atent owned by Takeda Pharmaceutical Company Limit...
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Chiropractors Focus on Patients Best Interest 54503 1Mississippi School Boards Association and Accelify Attain Clarity on New Medicaid Claiming Policy for Coming School Year 54501 1Mississippi School Boards Association and Accelify Attain Clarity on New Medicaid Claiming Policy for Coming School Year 54501 2Mississippi School Boards Association and Accelify Attain Clarity on New Medicaid Claiming Policy for Coming School Year 54501 3Ophthalmology Pioneer Dr Jeffrey P Gilbard Dies 54498 1Ophthalmology Pioneer Dr Jeffrey P Gilbard Dies 54498 2Ophthalmology Pioneer Dr Jeffrey P Gilbard Dies 54498 3
...nhua-PRNewswire-FirstCall/,-- Pharmaceutical compa...Phase II trial for Aridol in subjects with Chronic...ry disease,affecting over 30 million people worldw...D patients at 12,centres in Australia. The primary...ts that were positive to an Aridol challenge,test ...
...of key product in,AM-Pharma,s pipeline , BUNNIK, T...e,biopharmaceutical company developing novel thera...ses, today announced positive,results in patients ...re a subgroup of a Phase IIa trial with Alkaline P...earance, a marker for renal function,improved by ...
Other Medicine Technology:Pharmaxis Reports Phase II Results for Aridol in COPD 2Pharmaxis Reports Phase II Results for Aridol in COPD 3Pharmaxis Reports Phase II Results for Aridol in COPD 4AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial,with Alkaline Phosphatase in Acute Renal Failure 2AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial,with Alkaline Phosphatase in Acute Renal Failure 3
...fectively delivers clinically proven aminophylline...duction. Topical fat reduction with the aminophyll...on in fat and an increase in the firmness of the t...o the skin where it causes the body fat cells to s...
...ur is a non-invasive massage machine for skin, sca...m. Extraordinary results are achieved with our fam... vertical and parallel forces to produce effective...p tissue mobilization, kneading and compression, s...
Starvac SP2 Vacuum Cellulite Massage Therapy
Ritter 204 Manual Exam Table
Medicine Products: